Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducingend N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: Comparison between normal controls and patients with macular corneal dystrophy
N. Hasegawa et al., Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducingend N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: Comparison between normal controls and patients with macular corneal dystrophy, J BIOCHEM, 125(2), 1999, pp. 245-252
Human serum sulfotransferase activities were measured in normal controls an
d patients with macular corneal dystrophy (MCD), an inherited disorder char
acterized by the decreased sulfation of keratan sulfate in the corneal stro
ma and serum, using two kinds of acceptor: partially desulfated keratan sul
fate and a trisaccharide with a GlcNAc residue at the nonreducing terminal,
GlcNAc beta 1-3Gal beta 1-4GlcNAc. When partially desulfated keratan sulfa
te was used as the acceptor, only sulfotransferase activity which transfers
sulfate to position 6 of the Gal residues was detected, In contrast, when
GlcNAc beta 1-3Gal beta 1-4GlcNAc was used as the acceptor, sulfotransferas
e activity which transfers sulfate to position 6 of the nonreducing termina
l GlcNAc residue could be detected, Although keratan sulfate levels in the
sera of MCD patients determined by ELISA were much lower than those in norm
al controls, there were no detectable differences in either the sulfotransf
erase activity responsible for the sulfation of position 6 of Gal residues
or that responsible for the sulfation of position 6 of nonreducing end GlcN
Ac residues between normal controls and MCD patients, These results suggest
that the sulfotransferase involved in the sulfation of keratan sulfate, wh
ich is assumed to be deficient in MCD patients, may not be secreted into th
e serum, and that direct measurement of the sulfotransferase activity prese
nt in affected tissues such as the cornea instead of serum may be necessary
to confirm the postulated deficiency in the biosynthesis of keratan sulfat
e in MCD.